A transdiagnostic meta-analysis of physical and social Anhedonia in major depressive disorder and schizophrenia spectrum disorders

被引:11
|
作者
Gandhi, Arti [1 ]
Mote, Jasmine [2 ]
Fulford, Daniel [1 ,3 ]
机构
[1] Boston Univ, Sargent Coll Hlth & Rehabil Sci, 635 Commonwealth Ave, Boston, MA 02215 USA
[2] Tufts Univ, Sch Arts & Sci, Dept Occupat Therapy, 574 Boston Ave, Medford, MA 02155 USA
[3] Boston Univ, Dept Psychol & Brain Sci, 900 Commonwealth Ave, Boston, MA 02215 USA
关键词
Anhedonia; Schizophrenia; Depression; COGNITIVE CONTROL; NEURAL RESPONSE; SELF-ASSESSMENT; DEFICITS; EXPERIENCE; PEOPLE; REWARD; MOTIVATION; SYMPTOMS; PLEASURE;
D O I
10.1016/j.psychres.2021.114379
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Introduction: Anhedonia is a transdiagnostic construct conceptualized as physical or social, however, the extent to which these subtypes differ across psychotic and mood pathology remains poorly understood. We aimed to quantify the severity of physical and social anhedonia across Major Depressive Disorder (MDD) and Schizophrenia Spectrum Disorder (SSDs). Methods: We conducted meta-analyses of the Chapman Physical and Social Anhedonia Scales (PAS;SAS). We reviewed data from participants with MDD, and SSDs separately. Results: Our first meta-analysis (n = 8 studies, 409 participants) with MDD revealed elevated SAS and PAS in MDD compared to controls. Within-group differences were not significant. Depressive symptom severity moderated the between-group effect of PAS. Our second meta-analysis (n = 44 studies, 3352 participants) revealed elevated SAS and PAS in SSDs compared to controls. We detected a moderate difference between the SAS and PAS within the SSD group. Age moderated within-group differences of SAS and PAS. Discussion: People with SSD or MDD experience elevated SAS and PAS compared to controls. People with SSDs endorse greater challenges experiencing social rewards relative to physical rewards. People with MDD experience social and physical rewards similarly. The moderating role of depressive symptoms in MDD suggests that physical anhedonia is more state-like than social anhedonia.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Cross-Disorder Meta-Analysis of Endocannabinoid DNA Variations in Major Depressive Disorder, Bipolar Disorder, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder, and Schizophrenia
    Kim, Helena K.
    Goncalves, Vanessa
    Husain, Ishrat
    Mueller, Daniel
    Kennedy, James
    Mulsant, Benoit
    Zai, Gwyneth
    Kloiber, Stefan
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 173 - 173
  • [32] Physical and social anhedonia are associated with suicidality in major depression, but not in schizophrenia
    Sagud, Marina
    Tudor, Lucija
    Simunic, Lucija
    Jezernik, Dejana
    Madzarac, Zoran
    Jaksic, Nenad
    Mihaljevic Peles, Alma
    Vuksan-Cusa, Bjanka
    Simunovic Filipcic, Ivona
    Stefanovic, Ivana
    Kosanovic Rajacic, Biljana
    Kudlek Mikulic, Suzan
    Pivac, Nela
    SUICIDE AND LIFE-THREATENING BEHAVIOR, 2021, 51 (03) : 446 - 454
  • [33] A systematic review and meta-analysis of optical coherence tomography studies in schizophrenia, bipolar disorder and major depressive disorder
    Prasannakumar, Akash
    Kumar, Vijay
    Mailankody, Pooja
    Appaji, Abhishek
    Battu, Rajani
    Berendschot, Tos T. J. M.
    Rao, Naren P. P.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2023, 24 (08): : 707 - 720
  • [34] A meta-analysis of craving studies in schizophrenia spectrum disorders
    Donde, Clement
    Achim, Amelie M.
    Brunelin, Jerome
    Poulet, Emmanuel
    Mondino, Marine
    Haesebaert, Frederic
    SCHIZOPHRENIA RESEARCH, 2020, 222 : 49 - 57
  • [35] Exploration of first onsets of mania, schizophrenia spectrum disorders and major depressive disorder in perimenopause
    Lisa M. Shitomi-Jones
    Clare Dolman
    Ian Jones
    George Kirov
    Valentina Escott-Price
    Sophie E. Legge
    Arianna Di Florio
    Nature Mental Health, 2024, 2 (10): : 1161 - 1168
  • [36] Relationships between social or physical anhedonia and depressive symptoms in acute schizophrenia
    Kontaxakis, VP
    Kollias, CT
    Havaki-Kontaxaki, BJ
    Stamouli, SS
    Christodoulou, GN
    EUROPEAN PSYCHIATRY, 2004, 19 : 166S - 167S
  • [37] Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia
    Kim, Helena K.
    Gonsalves, Vanessa F.
    Husain, Muhammad I.
    Mueller, Daniel J.
    Mulsant, Benoit H.
    Zai, Gwyneth
    Kloiber, Stefan
    PSYCHIATRY RESEARCH, 2023, 330
  • [38] Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
    Vancampfort, Davy
    Stubbs, Brendon
    Mitchell, Alex J.
    De Hert, Marc
    wampers, Martien
    Ward, Philip B.
    Rosenbaum, Simon
    Correll, Christoph U.
    WORLD PSYCHIATRY, 2015, 14 (03) : 339 - 347
  • [39] Adjunctive brexpiprazole for treating major depressive disorder, meta-analysis
    Yoon, S.
    Han, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S462 - S463
  • [40] Meta-Analysis of Functional Neuroimaging in Adults With Major Depressive Disorder
    Klassen, Amanda M.
    Baten, Caitlin
    Shepherd, Jonah H.
    Zamora, Gladys
    Saravia, Sarah
    Pritchard, Elizabeth
    Ali, Zulaikha
    Jordan, Jillian
    Kahlon, Saneh K.
    Maly, Grace
    Duran, Marisol
    Santos, Shay L.
    Kaur, Anmol
    Saini, Aran
    Nimarko, Akua F.
    Hedges, Dawson W.
    Hamilton, J. Paul
    Gotlib, Ian H.
    Sacchet, Matthew D.
    Miller, Chris H.
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S207 - S207